Objective:

To analyze the shortcomings of AI tools in life sciences R&D, particularly their failure to meet scientific standards, and propose a path forward.

Key Findings:

• AI tools have not significantly improved scientific productivity due to their inability to meet scientific standards of evidence and reasoning, as well as a lack of trust.
• Most early AI deployments were based on flawed assumptions about their applicability in R&D, leading to ineffective tools.
• The gap in trust arises from the lack of traceability and the ability to interrogate AI outputs, which are crucial for scientific decision-making.
• Organizations need to adapt their approach to AI by focusing on core capabilities while allowing for customization in specific workflows to enhance effectiveness.

Interpretation:

The failure of AI tools in R&D stems from their inability to provide the necessary rigor and transparency required in scientific work, rather than resistance from scientists.

Limitations:

• The complexity of biological systems makes standardization and automation more challenging, complicating AI integration.
• Current AI systems may not adequately address the nuanced needs of scientific inquiry, leading to gaps in functionality.

Conclusion:

Future success in AI for R&D will depend on aligning technology with scientific realities, prioritizing quality and transparency over superficial features, and ensuring tools can be trusted.